Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 8Prostatic Neoplasms 6Neoplasms, Plasma Cell 6Sarcoma 5Neoplasms 5Melanoma 4Liver Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Hepatocellular 4Lymphoma, Follicular 3Leukemia 3Carcinoma, Renal Cell 3Brain Neoplasms 3Myelodysplastic Syndromes 2Lymphoma 2Kidney Neoplasms 2HIV Infections 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Urologic Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Stomatitis, Aphthous 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Endometrial Stromal 1Recurrent Uterine Corpus Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1

Interventions

Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Oral Ulcer × Thalidomide × Clear all
NCT00001524 2008-03-04

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
110 enrolled

Acquired Immunodeficiency Syndrome, Burning Mouth Syndrome, Stomatitis, Aphthous, HIV Infections, Oral Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡